Amarin Corp Plc (AMRN)

[KCSVEN]

Maybe, depends on the deal and who is the EU partner, if its someone that may buy the company down the line and they pay a good premium then it would help stock price. If they get similar deal with royalties they would have huge cash hoard to launch US. There is something to it hurting BO chance and thus stock price as GIA is more risky in street view. But details of EU deal would be important.

Considering where SRP-9001 is at in the clinical pipeline and the risks with that drug Amarin should get multiples of what Sarepta got for international rights of Vascepa. Though I suspect Amarin will sell EU and not all international rights

They need to make a decision there by mid-year so any partner can get a jump. The sooner the better, let's have a forceful direction on EU. Either sell the company or make a deal and get some heavy cash flow for launch of US.